75N93020C00040

ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75N93020C00040
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER
Source: USASpending (Federal)
Source ID: usa-75N93020C00040

Details

Location: United States

Description

ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER Awarded to: AURO VACCINES LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT

Dates

Publication: 2020/07/21 12:00:00 AM UTC
Closing date: 2026/12/31 12:00:00 AM UTC

Estimated value

$10.7M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-11, 10:38:41 p.m.

Data refreshed every 2 hours